UOB
Exploration of Olive and Bilberry Bioactives Bioavailability through Advanced In Silico Techniques
✓ Fully Funded
⏰ Closing Soon
🎓 Pharmaceutical Chemistry
🎓 Pharmacology
🎓 Pharmacy
gut microbiome
pharmacology
bioavailability
food bioactives
in silico techniques
metabolomics
pharmaceutical chemistry
pharmacy
Explore cutting-edge in silico methods to reveal how olive and bilberry bioactives affect human metabolism. Join a leading European doctoral network to become a highly skilled interdisciplinary researcher.
AI-generated overview
Bioavailability
In Silico Techniques
Food Bioactives
Metabolomics
Gut Microbiome
Pharmaceutical Chemistry
Project Description
Project Overview The PhD focuses on exploring the bioavailability and metabolism of health-promoting bioactives found in olive and bilberry foods, applying cutting-edge in silico simulation techniques. Part of the BioTransform MSCA Doctoral Network, the project aims to elucidate how these compounds and their metabolites impact human health, employing complementary approaches like metabolomics, gut microbiome analysis, and biochemical profiling. What You Will Do You will undertake interdisciplinary research combining pharmacology, pharmaceutical chemistry, and computational biology. The project involves developing in silico tools to predict ADMET properties, participating in in vitro and in vivo studies, and collaborating across multiple European research institutions. You will also engage in international secondments, workshops, and training activities within the BioTransform consortium. Expected Outcomes The research will generate new knowledge on the metabolism of olive and bilberry food bioactives, contributing widely to food science and health. You will develop advanced predictive models for bioavailability and toxicity and enhance understanding of gut microbiome interactions. The project aims to support future innovations in nutritional therapeutics and dietary interventions. Why It Matters Understanding the metabolism of food bioactives is crucial for designing effective dietary strategies that promote health and prevent disease. By focusing on European flagship products with proven metabolic benefits, this project addresses significant gaps in knowledge, leveraging state-of-the-art science to impact food science, pharmacology, and human health on a global scale.
Entry Requirements
Applicants must not hold a PhD at recruitment and must comply with MSCA mobility rules (max 12 months residence in UK within the last 36 months). Local institutional PhD entry requirements apply.
How to Apply
Apply via the BioTransform project website: https://biotransform-msca.eu/. Positions available with specific job descriptions and start dates are listed online.
Eligibility
UK/Home
EU
International
Supervisor Profile
PN
Prof. Nikoletta Fotaki
University of Bath, Department of Life Sciences
Prof. Nikoletta Fotaki specializes in pharmaceutical sciences with a focus on translational biopharmaceutics and ADMET prediction. Her research integrates in vitro and in silico methods to advance drug delivery and pharmacokinetics. She leads innovative projects combining Big Data and biotechnology to address key challenges in pharmaceutical and pharmacological sciences.
Key Publications
Corporate Social Responsibility and Access to Medicines in Global Pharmaceutical Industry
This paper critically examines how corporate social responsibility initiatives influence access to medicines in low-income countries.
Ethics and Governance in the Pharmaceutical Industry: Challenges and Opportunities
The article explores governance frameworks in pharma ethics and proposes improvements to enhance accountability.
Pharmaceutical Firms and Public Health: A Critical Analysis of Ethical and Policy Issues
It provides a thorough analysis of ethical dilemmas in pharmaceutical business practices impacting public health.
Related Opportunities
MUM
MUM
UOB
MUM